RecruitingPhase 2NCT05243654

Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy

Studying Leprosy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Oxford University Clinical Research Unit Indonesia
Principal Investigator: Hardiyanto Soebono, Prof.Dr.dr
Center of Tropical Medicine, University of Gadjah Mada
Intervention: Metformin(drug)
Enrollment: 166 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2022 – 2026

Study locations (6)

Sitanala Leprosy Hospital, Tangerang, Banten, Indonesia
Palangga Health Center, Makassar, South Sulawesi, Indonesia
Bajeng Health Center, Makassar, South Sulawesi, Indonesia
Abe Pantai Community Health Center, Jayapura, Special Region of Papua, Indonesia
Hamadi Community Health Center, Jayapura, Special Region of Papua, Indonesia
Jayapura Utara Community Health Center, Jayapura, Special Region of Papua, Indonesia

Collaborators

University of Gadjah Mada, Faculty of Medicine · University of Diponegoro · Papua Agency of Health Research and Development (NIHRD) · London School of Hygiene and Tropical Medicine · Radboud University Medical Center · Oxford University Clinical Research Unit

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05243654 on ClinicalTrials.gov

Other trials for Leprosy

Additional recruiting or active studies for the same condition.

See all trials for Leprosy →

← Back to all trials